WallStreetZenWallStreetZen

NASDAQ: MYNZ
Mainz Biomed Nv Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MYNZ

Based on 1 analyst offering 12 month price targets for Mainz Biomed Nv.
Min Forecast
$3.00+245.22%
Avg Forecast
$3.00+245.22%
Max Forecast
$3.00+245.22%

Should I buy or sell MYNZ stock?

Based on 1 analyst offering ratings for Mainz Biomed Nv.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MYNZ stock forecasts and price targets.

MYNZ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-06

1 of 1

Forecast return on equity

Is MYNZ forecast to generate an efficient return?

Forecast return on assets

Is MYNZ forecast to generate an efficient return on assets?

MYNZ revenue forecast

What is MYNZ's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.3M+45.17%

MYNZ vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
MYNZ$0.87$3.00+245.22%Buy
OCX$2.46$3.90+58.86%Buy
DMTK$0.62$1.38+123.54%Buy
TTOO$2.72N/AN/A
PMD$2.59N/AN/A
View Top Diagnostic & Research Stocks

Mainz Biomed Nv Stock Forecast FAQ

Is Mainz Biomed Nv Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MYNZ) stock is to Buy MYNZ stock.

Out of 1 analyst, 0 (0%) are recommending MYNZ as a Strong Buy, 1 (100%) are recommending MYNZ as a Buy, 0 (0%) are recommending MYNZ as a Hold, 0 (0%) are recommending MYNZ as a Sell, and 0 (0%) are recommending MYNZ as a Strong Sell.

If you're new to stock investing, here's how to buy Mainz Biomed Nv stock.

What is MYNZ's revenue growth forecast for 2024-2024?

(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Mainz Biomed Nv's revenue in 2024 is $895,479.

In 2024, MYNZ is forecast to generate $27,515,127 in revenue, with the lowest revenue forecast at $27,515,127 and the highest revenue forecast at $27,515,127.

What is MYNZ's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: MYNZ) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 10.86%.

What is MYNZ's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MYNZ price target, the average MYNZ price target is $3.00, with the highest MYNZ stock price forecast at $3.00 and the lowest MYNZ stock price forecast at $3.00.

The Wall Street analyst predicted that Mainz Biomed Nv's share price could reach $3.00 by Mar 6, 2025. The average Mainz Biomed Nv stock price prediction forecasts a potential upside of 245.22% from the current MYNZ share price of $0.87.

What is MYNZ's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: MYNZ) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.